???‚¬?? For the treatment of patients with acute coronary syndrome including patients who are to be managed medically and those undergoing percutaneous coronary intervention (PCI). it has been shown to decrease the rate of a combined endpoint of death or new myocardial infarction. ???‚¬?? For the treatment of patients undergoing PCI, including those undergoing intracoronary stenting. In this setting, it has been shown to decrease the rate of a combined endpoint of death, new myocardial infarction, or need for urgent intervention.
|